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Abstract
Integrating POC CD4 testing technologies into HIV counseling and testing (HCT) programs may improve post-HIV testing
linkage to care and treatment. As evaluations of these technologies in program settings continue, estimates of the costs of
POC CD4 tests to the service provider will be needed and estimates have begun to be reported. Without a consistent and
transparent methodology, estimates of the cost per CD4 test using POC technologies are likely to be difficult to compare
and may lead to erroneous conclusions about costs and cost-effectiveness. This paper provides a step-by-step approach for
estimating the cost per CD4 test from a provider’s perspective. As an example, the approach is applied to one specific POC
technology, the Pima
TM Analyzer. The costing approach is illustrated with data from a mobile HCT program in Gauteng
Province of South Africa. For this program, the cost per test in 2010 was estimated at $23.76 (material costs=$8.70; labor
cost per test=$7.33; and equipment, insurance, and daily quality control=$7.72). Labor and equipment costs can vary
widely depending on how the program operates and the number of CD4 tests completed over time. Additional costs not
included in the above analysis, for on-going training, supervision, and quality control, are likely to increase further the cost
per test. The main contribution of this paper is to outline a methodology for estimating the costs of incorporating POC CD4
testing technologies into an HCT program. The details of the program setting matter significantly for the cost estimate, so
that such details should be clearly documented to improve the consistency, transparency, and comparability of cost
estimates.
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Introduction
In most resource-limited countries, eligibility for antiretroviral
therapy (ART) for HIV/AIDS is based on a count of CD4+ T-
lymphocytes. Traditional CD4 count technologies require that a
venous blood sample be processed by a laboratory. After testing
positive for HIV infection, patients either provide a blood sample
immediately or are referred to another facility if the HIV
counseling and testing (HCT) site does not take blood samples.
The blood sample is then sent to a laboratory for processing.
Depending on laboratory capacity, results are typically available
between 2 and 14 days after the patient has provided the sample.
Patients are asked to return to the clinic to receive their results,
after which they are referred for future HIV care and/or
treatment.
The existing literature based on data from sub-Saharan Africa
suggests that an average of 40% of patients diagnosed with HIV
infection either do not provide a blood sample or do not return to
obtain their CD4 count results. [1,2,3,4,5,6] One solution
proposed to address this problem is the incorporation of rapid,
point-of-care (POC) CD4 testing technologies into HCT pro-
grams. For example, the Pima
TM Analyzer (Alere) is a rapid POC
CD4 testing technology that is being validated in various settings.
[7,8,9,10,11,12] Because of the cartridge-based system and small
size of the unit, it can be used in non-laboratory settings such as in
mobile and fixed-site HCT programs and in antenatal clinics. A
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[13]
Evidence for the impact of POC CD4 testing on linkage to HIV
care and treatment after HIV testing is limited but positive. One
study from Mozambique reported a reduction in total loss to
follow-up before initiation of antiretroviral treatment from 64% to
33%. [14] In another study from South, the introduction of POC
CD4 testing increased the proportion of ART-eligible patients
(CD4 cell counts#215) who initiated ART within 3 months of
HIV testing. [15] However, for patients with higher CD4 cell
counts (.215), fewer patients reported for pre-ART care. [15]
As attention shifts from validation of the POC technologies to
the evaluation of their impacts on care and treatment outcomes,
such as post-HCT enrollment in care and earlier initiation of
ART, estimates of the costs of POC CD4 tests to the service
provider will be needed for budgeting and cost-effectiveness
analyses and estimates have begun to be reported. [16] The
usefulness of these and future estimates will depend in large part
on applying a costing methodology that is logical for the specific
technology and consistently applied across countries, studies, and
programs. Although methods for evaluating the costs of health
interventions are well documented [17], costs typically depend on
the details of the intervention and the context in which it is
implemented. Without a consistent and transparent methodology,
estimates of the cost per CD4 test using POC technologies, such as
the Pima
TM Analyzer, are likely to be difficult to compare and
may lead to erroneous conclusions by program managers, funding
agencies, and researchers concerning budgetary impacts and cost-
effectiveness.
This paper provides a step-by-step approach for estimating the
cost per CD4 test from a provider’s perspective. As a concrete
example, we apply this approach to one specific POC technology,
the Pima
TM Analyzer. This approach shows how to document
explicitly the data and assumptions used to estimate the cost per
test, which are needed to interpret and evaluate cost estimates.
The example is illustrated with recent cost data from a mobile
HCT program in Gauteng province of South Africa. [18] The
paper aims to contribute to the quality of future evaluations of new
POC testing technologies, such as the Pima
TM Analyzer, by
improving the consistency, transparency, and comparability of cost
information.
Methods
The total cost to a provider of a POC CD4 test depends on
many individual pieces of information. These include the material
costs per test, the salaries of staff who conduct start-up and daily
quality control activities on the machine, the salaries of staff who
perform the CD4 test, how the technology is integrated into
patient flow and management, equipment and other related costs
(e.g., insurance, replacement parts), the expected working life of
the technology itself, and the opportunity cost of funds used to
acquire the technology (i.e. the discount rate). To capture this
information in an organized and consistent manner, the costing
approach proceeds through six data input tables and associated
calculations to estimate:
(1) material costs per test;
(2) staff time per test;
(3) salary costs per test;
(4) costs of daily startup and quality control;
(5) equipment costs (daily equivalent costs); and
(6) average number of tests completed per day when the unit is
used.
The information from these 6 tables is then combined into a
final table that estimates the cost of a POC CD4 test from the
provider perspective. This approach can be used to evaluate the
cost per test using any technology. The details of each step follow
logically from the technology used as well as the program in which
it is used.
The mobile program information and data used in this analysis
are from a South African program implemented during 2010 in
Gauteng Province, and all cost are reported in U.S. dollars (costs
converted from South Africa Rand to US$ at 7.5 R/$US). This
costing analysis does not involve human subjects’ research. The
analysis relies on readily information on various costs and basic
estimates of time use to complete various tasks.
Results
Material costs per test (Table 1)
Documenting the cost of materials used for each test is the first
step in the costing analysis. As outlined in Table 1 for the Pima
technology, these materials include a pair of gloves, the Pima
sample collection kit, the test cartridge, and paper for printing the
results. All costs included South Africa VAT (14%). The total
materials cost per test is $8.70, with the Pima CD4 single-use test
cartridge comprising 91% of the cost.
Another type of CD4 testing technology would obviously
require different types of materials so that the details of Table 1
need to be adjusted logically to be consistent with the materials
needed based on the POC technology.
Staff time per test (Table 2)
If POC CD4 testing is integrated into HCT programs,
providing this service requires additional time of HCT staff
members. How much additional staff time depends on how the
testing and counseling processes are organized at the site. The
information in Table 2 was based on informal interviews with staff
members (nurses) of the South African mobile program. In this
setting, CD4 testing is estimated to have added 5 minutes to pre-
HIV test counseling when the possibility of CD4 testing was
discussed with the patient, 5 minutes to post-HIV test counseling
to ascertain if the patient wanted to complete a CD4 test, and 5
additional minutes of counseling after the results of the CD4 test
were obtained. Table 2 also provides two other scenarios for staff
time per test, with a low-end estimate of 2 additional minutes and
a high-end estimate of 25 minutes.
In addition to the 15 minutes total for counseling related to the
CD4 test, running the test requires staff time. For the Pima
TM
technology, where one test can be run at a time, the typical time
per test is 30 minutes (from opening the sample collection kit
through the generation of results), of which 20 minutes involves
waiting for the machine to complete the test once the cartridge is
inserted. If the person running the test did nothing else during
these 20 minutes, a total of 45 minutes of staff time would be
required for each test (15 minutes for the counseling activities and
30 minutes total for the test).
In the South African mobile program, one nurse provided all
care to one patient at a time, including the POC CD4 test. Rather
than doing nothing during the 20 minutes while the test was
running, the nurses could typically complete other activities during
a portion of this time (e.g., begin counseling on CD4 test results,
complete paper work, and so on). In Table 2, an estimate of
15 minutes of staff time to complete the CD4 test (10 minutes for
sampling and test preparation, and 5 minutes not otherwise
engaged while the test is running).
Cost of a Point-of-Care CD4 Test
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staff time per CD4 test is estimated at 30 minutes. Table 2 also
includes a low-end estimate of 12 minutes per test, which could be
achieved by a program with little counseling and a staff member
dedicated only to running the POC tests who can accomplish
other activities while the test is running. A high-end estimate of
50 minutes per test is also included in Table 2, which could be
relevant for programs with intensive counseling programs and if
staff members do nothing else while waiting for the test results.
The process outlined in Table 2 can be followed to estimate the
staff time per test for any type of CD4 testing technology. While
the mobile program included in Table 2 used the same category of
staff (nurses) for all activities, other programs would likely use
different staff categories for different activities. For example, a
HIV counselor might complete counseling activities, a nurse might
obtain the blood sample, and a laboratory technician might run
the test, and so on. For other situations, the same process as
outlined in Table 2 can be followed with the appropriate
adjustments.
Salary cost per working hour and per test (Table 3)
Table 3 develops an estimate of the full staff salary per working
hour that can be combined with the time information in Table 2 to
estimate salary cost per test. The mobile program offers a very
simple example because nurses were used for all patient services in
the mobile program, and the nurses were hired daily at a rate
$117.33 per day. With 8 working hours in a day, this translates to
$14.67 per working hour and $7.33 per test in the mobile
program, which required half an hour per test.
For programs in which multiple levels of staff are involved,
Table 3 also provides an example using three different levels of
nurses (Department of Public Service and Administration, 2011).
The full cost of salary and benefits (e.g. housing allowance, taxes
paid by the employer, retirement benefits, and so on), sometimes
labeled ‘‘cost to company,’’ should be included. While there are
typically 260 working days in a year, most employees actually work
substantially less than this, due to holidays, annual leave, and sick
leave. Nurses in the South Africa program work on average 215
days per year (17.9 days per month). With 8 working hours per
day, the salary per working hour would range from $8.81 for the
enrolled nurse category (average of salary range for category
reported in Table 3) to $24.60 for the professional nurse category.
Using the same additional time per test as for the mobile
program (0.5 hours), the salary costs per test could range from
$4.40 to $12.30 depending on the level of staff used in a program.
This number could fall to below $2.00 if a low-paid nurse worked
in a program that completed tests very quickly, or rise to $20.50
for a high-paid nurse in a time-intensive program. In other settings
and in other countries, the same processes outlined in Table 3 can
be followed to estimate staff costs per test.
Cost for daily quality control (Table 4)
Each day a POC machine is used, it typically must be turned on
and quality controls run. For the PIMA technology, a cartridge (e.g,
a Pima
TM Bead Standard, $41.60) is inserted into the machine, with
recommended control cartridge replacement every six calendar
months regardless of how often the machine is used during that
time. The machine is unlikely to be used every working day in many
HCT settings due to holidays, staff meetings, and so on. In Table 4
(seeTable 4),16dayspermonth is included,reflectingan average of
four days per week when the machine is used. In this case, the total
cost per day for quality control is estimated at $7.77 in the mobile
program, with additional estimates based on the different levels of
nurses included in Table 3.
Table 1. Material costs per POC test*.
Item Unit US$ 2010 % of total
Gloves, powder free Cost per test $0.01 0.11%
Pima Finger Stick Sample Collection Kit (includes
plaster, gauze, alcohol swab, Pima lancet)
Cost per test $0.67 7.70%
Pima test cartridge Cost per test $7.96 91.49%
Printing CD4 results Cost per test $0.06 0.69%
Total materials cost per test Cost per test $8.70 100.00%
*Exchange rate=7.5 R/$US. All costs include South Africa’s value-added tax (14%). Glove cost per test based on 500 powder-free gloves for R29 (National Health
Laboratory System). Sample collection kit based on price quote from Alere R501.60 per 100). Test cartridge cost based on price quote from Alere (R5,969.04 for package
of 100). Printing cost per test based on R1114.92 per package of printer rolls (10 rolls per pack, 50 reports per roll from Printer documentation).
doi:10.1371/journal.pone.0035444.t001
Table 2. Staff time per POC test.
Activity Units Mobile Program Scenario A: minimal time Scenario B: labor-intensive
Pre-test counseling (HIV testing) minutes per patient 5 0 5
Post-test counseling (HIV testing) minutes per patient 5 1 10
Additional counseling on POC results minutes per patient 5 1 10
Complete POC CD4 test minutes per patient 15 10 25
Total time minutes per patient 30 12 50
Staff time per POC CD4
test (hours)
hours per patient 0.50 0.20 0.83
doi:10.1371/journal.pone.0035444.t002
Cost of a Point-of-Care CD4 Test
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If POC CD4 testing is to be offered, the technology needs to be
acquired by the program. How the technology is acquired, and
under what conditions, must be considered. For example, the price
to purchase a Pima
TM Analyzer, the Pima
TM Printer, and the
carrying bag was quoted at $7,431.28, which includes 14% VAT.
A one-year warranty is provided by the manufacturer on the
equipment. While the Pima requires no maintenance by the
purchaser, the unit has parts that may require replacement over
time (the battery, hinges on door, PC boards, display screen). The
Table 3. Salary cost per working hour and per test.
Type of staff member* Units
Mobile Program
(nurse paid flat
daily rate) Enrolled nurse Staff nurse
Professional
nurse Note:
Salary (including all benefits
according to SA
government policy)
USD/month NR $1,262.18 $2,228.59 $3,492.69
Total potential working
days per year
Days/year NR 260.00 260.00 260.00
Annual leave Days/year NR 21.00 22.00 22.00
Sick leave Days/year NR 10.00 10.00 10.00
National holidays Days/year NR 14.00 15.00 15.00
Actual working days per year Days/year NR 215.00 213.00 213.00
Actual working days
per month
Days/month NR 17.92 17.75 17.75
Nurse salary per actual
working day
USD/day working $117.33 $70.45 $125.55 $196.77
Working hours per day hours per day 8.00 8.00 8.00 8.00
Nurse salary per working hour salary/hour working $14.67 $8.81 $15.69 $24.60
Staff time per POC CD4
test (hours)
Hours per test (mobile
program)
0.50 0.50 0.50 0.50 From
Table 2
Nurse salary cost per test Cost per test (mobile
program)
$7.33 $4.40 $7.85 $12.30
ALTERNATIVE SCENARIOS
Staff time per POC CD4
test (hours)
Hours per test (Scenario A) 0.20 0.20 0.20 0.20 From
Table 2
Nurse salary cost per test Cost per test (Scenario A) $2.93 $1.76 $3.14 $4.92
Staff time per POC CD4
test (hours)
Hours per test (Scenario B) 0.83 0.83 0.83 0.83 From
Table 2
Nurse salary cost per test Cost per test (Scenario B) $12.22 $7.34 $13.08 $20.50
doi:10.1371/journal.pone.0035444.t003
Table 4. Costs for daily quality control.
Units Completed by staff nurse
Machine start up time daily (machine
turned-on and controls run)
hours per day 0.5
Salary cost per hour salary/hour working (mobile program nurse from Table 3) $14.67
Salary cost per day for quality control
when machine used
Cost per day $7.33
Cost of ‘‘Pima Bead Standard’’ daily
quality control (lasts for 6 months once opened)
Cost per cartridge (inc. VAT) $41.60
Days unit used per month Days 16
Number of working days in 6 months Days per 6 months 96
Cost per day of Pima Bead Standard Cost per day $0.43
Total cost per day for quality control Cost per day (mobile program nurse) $7.77
Cost per day (enrolled nurse) $4.84
Cost per day (staff nurse) $8.28
Cost per day (professional nurse) $12.73
doi:10.1371/journal.pone.0035444.t004
Cost of a Point-of-Care CD4 Test
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plan can be purchased from $1200 per year from Alere to cover
such costs or failures after the warranty period. For this analysis,
we assume that the program purchases the insurance. The issue is
how to translate the up-front costs and additional insurance costs
incurred in the future into a daily equivalent cost (and eventually a
cost-per test completed).
Table 5 shows how to estimate the costs of equipment costs and
insurance into an equivalent amount per day that the equipment is
actually used. To begin, two issues need to be addressed: the
working life of the equipment and the discount rate used for
comparing costs over time.
Regarding the life of the equipment, relatively little information
exists on the working life of new equipment under operational
conditions. The machine could stolen, dropped and broken, or get
wet, all of which are real possibilities especially in mobile HCT
programs. For a new technology, even the average working life
under good conditions is uncertain.
Regarding the discount rate, numerous texts are devoted to the
appropriate discount rate to use when evaluating investment
projects in the private and public sectors. [19] In South Africa in
2010, the prime interest rate for borrowing (best borrowers) was
approximately 10%, with inflation at 5%. An annual real interest
rate (nominal minus inflation) of 5% would be relevant for
financially solid programs that could borrow to purchase the
equipment. As a rough approximation, an annual rate of 5% can
be converted to a monthly rate of 5%/12=0.4167%. A more
precise calculation can be found in standard texts and online (e.g.,
http://www.stoozing.com/mon2yr.htm), which yield 0.407%. In
most program evaluation situations, the simple conversion
approach is more than adequate.
Based on up-front equipment costs of $7,341 and the$1,200
insurance plan beyond the warranty period, Table 5 (Step 2)
summarizes the present value of equipment costs depending on the
working life of the equipment and the discount rate. For example,
if the equipment lasts for 4 years, the program purchases insurance
for 3 years beyond the warranty period, and a 0% discount rate is
Table 5. Equipment costs*.
Step 1. Up-Front Equipment costs
Testing unit $6,688.00
Printer $490.50
Bag $252.78
Total equipment costs $7,431.28
Equipment includes 1 year warranty
After one year, annual care plan for
equipment
$1,200.00
Step 2. Present value of equipment
costs with insurance
Scenarios
working life of equipment in years R 54 3 2
years insurance purchased R 43 2 1
Present value of equipment costs
with insurance
0% $12,231 $11,031 $9,831 $8,631
5% $11,686 $10,699 $9,662 $8,574
8% $11,408 $10,523 $9,571 $8,542
Step 3. Monthly equivalent
equipment costs
Multiple scenarios working life in months= =.
Annual discount rate 60 48 36 24
0% $203.85 $229.81 $273.08 $359.63
5% $220.53 $246.39 $289.58 $376.15
8% $231.31 $256.90 $299.92 $386.33
Step 4. Daily equivalent
equipment costs
Days unit used on average per month
(same as in Table 4)
16
Working life of equipment and discount rates? working life in months= =.
Discount rate 60 48 36 24
0% $12.74 $14.36 $17.07 $22.48
5% $13.78 $15.40 $18.10 $23.51
8% $14.46 $16.06 $18.75 $24.15
doi:10.1371/journal.pone.0035444.t005
Cost of a Point-of-Care CD4 Test
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$7,341+$1,200+$1,200+$1,200=$11,031. With discounting, for
example using a 5% rate, the present value of costs are somewhat
lower ($7,341+$1,200/(1.05)+$1,200/(1.05)
2+$1,200/1.05)
3=$10,699).
This analysis uses standard procedures of calculating the present
value of a stream of costs over time. [19]
For this analysis, we assume that the insurance plan covers any
needed repairs. If an insurance plan is not available or an
organization decided not to purchase such a plan, the likely costs
of repairs and maintenance over time would need to be included
nonetheless into the analysis.
Table 5, Step 3, provides a range of monthly equivalent costs for
the Pima equipment with different assumptions about working life
(60-24 months), the discount rate (0–8%), and the associated
present value of equipment costs from Step 2. Monthly costs could
be as low as $203 if the program assumed money was free (0%
discount rate) and the technology lasted for 5 years. The costs
would be over $350 per month if the technology lasted for 2 years
(or perhaps was stolen after two years). The ‘‘pmt’’ function in
Excel is easy to use for this step in the analysis. For example, with
total equipment costs of $10,699 assuming a 4 year working and
5% annual discount rate, the payment function is coded
as=pmt(0.05/12, 48, $10,699, 0, 0), which yields $246.39.
Table 5, Step 4, then converts these monthly costs into an
equivalent cost per day that the equipment is used. For the mobile
program included in this example, the site typically operates
mobile HCT activities 4 days per week (16 days per month).
Assuming as a base case that the working life is 4 years (48 months)
and a 5% annual discount rate, $15.40 is the estimated daily cost
of the up-front equipment purchase along with the annual
insurance plan.
Number of tests per day and per year (Table 6)
Once the daily cost of the equipment has been calculated
(Table 5), the number of tests completed on average per day is
required to estimate the equipment cost per test. Table 6 includes
assumptions on the number of tests run per day (3, 5, 10, and 15).
In the case of the Pima technology, which can only process one
test at a time, an average of 30 minutes is needed from start
(preparing to collect blood through a finger prick) to finish per test,
and approximately 30 minutes to start the machine and run
quality controls daily. In an eight-hour day, the theoretical
maximum number of tests that could be completed with one
machine in an eight-hour working day is 15. With 4 days per week
and 52 weeks per year, an annual theoretical maximum per
machine is 2880 tests in the mobile program. Due to holidays, a
realistic maximum would be less.
Most mobile sites, as well as fixed HCT programs, would
typically perform fewer than 15 tests per day as a long term
average due to inconsistent patient flow. When the Pima
TM
machine was used in the mobile program, 3 tests per day per
machine was typical.
Total cost per test (Table 7)
Using the data, assumptions, and calculations in Tables 1, 2, 3,
4, 5, and 6, Table 7 provides a summary of the financial costs to
the program providing the POC test. In Table 7, the total cost per
test for the mobile program is estimated at $23.76. All of the
assumptions and information included in this estimate are
contained in Tables 1, 2, 3, 4, 5, and 6.
Because one test can be run at a time with the Pima machine,
the resulting daily capacity constraint implies that there is little
room for economies of scale to reduce the cost per test. Moving
from 3 to 5 tests per day on average would reduce the cost per test
to $20.67. With 15 tests per day on average, which is unlikely to be
achieved in a mobile program, the cost would fall to $17.58.
In Table 7, one final piece of information is needed. Based on
experience in the mobile program, some failure rate needs to be
included in the analysis. In the case of the Pima technology, the
machine provides an error code if the CD4 test is not successfully
completed, but the reason for the error may not be clear.
Possibilities include not obtaining an adequate blood sample as
well as shaking of the equipment (e.g., when used inside a mobile
testing van and staff are moving around in the van while a sample
is processing). In Table 7, when a 3% failure rate is included in the
analysis, based on information from the mobile program, the costs
per test increase slightly. Results from a recent multisite evaluation
report a 14% failure rate using finger-prick blood. [11]
Discussion
As studies continue to assess the usefulness of POC CD4 testing
for improving patient care and strengthening linkage to care and
treatment after HIV testing, the cost of such tests will need to be
estimated in a range of settings, including mobile HCT programs,
fixed-site HCT programs attached to medical facilities, and those
not attached to a medical facility (e.g. youth centers). These
programs will need to estimate for their own situations the costs of
incorporating POC CD4 testing into their services and how to
adjust patient management and responsibilities of staff members to
provide the service with acceptable quality and costs.
In the example developed here, we estimated that the average
cost per CD4 test performed by the mobile HCT program using
the Pima Analyzer was $23.76. In comparison, the fee for
laboratory-based testing is around $7–8 per test. [12]
The first key message from this paper is that context matters,
and therefore the detailed assumptions of any costing analysis
needed to be reported along with ‘results’. The estimates of the
cost of POC CD4 testing, even with the same technology such as
the Pima Analyzer, will vary widely across countries (due to
Table 6. Number of tests completed per day and per year.
Tests per day Working days per year Test per year
Mobile progam 3 192 576
Other Testing Scenarios
Scenario T1 5 192 960
Scenario T2 10 192 1920
Scenario T3 15 192 2880
Note: Days per month from Table 4.
doi:10.1371/journal.pone.0035444.t006
Cost of a Point-of-Care CD4 Test
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structure (types of staff employed, time spent with patients).
A second key message is that the cost per test is driven by two
components: material costs per test and labor costs per test.
Individual HCT programs have little ability to adjust material
costs per test except through direct negotiation with the
manufacturer. As with pharmaceuticals, it is likely that the costs
of the cartridges in the case of the Pima technology (or reagents in
the case of other POC testing technologies) could fall as the size of
the market expands and bulk purchasing strategies are pursued.
Specific programs can manage their labor costs per test. In the
South African mobile program used as an example throughout this
analysis, nurses provided all HCT services (counseling, HIV
testing, CD4 testing during the piloting of the POC technology,
and so on). These nurses were paid an appropriate market wage in
the South Africa labor market ($14.67 per hour), and the estimated
labor cost per test in the mobile problem was $7.33. This labor
cost is far above the $0.16–$1.15 labor cost per test recently report
for a generic analysis. [20] To achieve $0.20 per test, a program
would need to pay labor $1.00 per hour, below the minimum wage
in South Africa, and complete all activities within 12 minutes.
Table 3 shows how the labor time per test and the wage rate
interact to create the labor costs per test. Low wage labor is clearly
one approach for keeping the costs of POC CD4 testing low.
Whether low wage and, therefore, relatively unskilled labor can be
used while maintaining high quality standards is yet to be seen.
Given recent analysis showing the importance of quality sample
collection for POC CD4 testing, [9] the ability to complete a valid
test quickly with low paid and, therefore, low skilled labor in South
Africa is questionable. One potential solution would be to provide
additional training and oversight for such staff. The additional
costs for training and oversight would then be included in the
analysis. In other countries with significantly lower wages than in
South Africa, it may be easier to keep labor costs low and test
quality high.
The analysis in this paper focuses on costs per test from a
provider’s perspective (an HIV counseling and testing program).
Three other sets of costs have not been included in this analysis.
First, in certain situations and countries, POC CD4 test results will
need to be integrated into existing electronic patient databases.
The additional health system costs of this integration, which might
include systems to scan patient IDs and results and transferring
data into databases managed at other locations.
Second, if POC CD4 testing is integrated into HCT programs,
general systems for staff training, quality control, and monitoring
and evaluation would likely need to be developed. The structure of
such systems and their costs, perhaps related to or modeled on
other quality assessment programs such as the African Regional
External Quality Assessment Scheme and the costs to sites of
participation, are not included in this analysis [21].
And third, as with most new service provided by organizations,
additional costs would be incurred to set up and integrate the
service into the program, such as procuring supplies, space to store
supplies and the equipment (nightly if used in the mobile
program), charging of the testing unit, stock control, and so on.
Organizations providing medical services already have stock
control systems in place (some better than others). Each site
would need to assess if their current systems and space would allow
easy integration of this additional service into their program
(including secure space for charging the unit). If relevant, losses in
storage could be easily incorporated into the cost analysis.
Point-of-care CD4 testing technologies allow HIV counseling
and testing programs as well as HIV care and treatment programs
to produce a CD4 test result more quickly than using traditional
technologies. We emphasize the word produce here because the
result is produced by the program providing the service, and the
structure of the program (especially patient management, types of
staff providing patient care, and life of the technology) have major
impacts on the cost to produce a CD4 test result. As programs
continue to evaluate the usefulness of integrating various types of
POC CD4 testing technologies into routine practice, the approach
outline in this paper, with all details provided in Tables 1, 2, 3, 4,
5, 6, and 7, can be replicated and adjusted as needed for the
specific technology to develop reasonable cost estimates.
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